Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Obenyl is a proprietary Ayurvedic multi-herb formulation developed by Charak Pharma for weight management and lipid regulation. It is composed of several key natural ingredients, including Kokum (Garcinia indica), Shuddha Guggul (Balsamodendron mukul), Atasi (Linum usitatissimum / flaxseed), Makandi (Coleus forskohlii), Isabgol (Plantago ovata / psyllium husk), and Katuki (Picrorhiza kurroa). The formulation works synergistically to regulate metabolism, suppress appetite, reduce fat accumulation, and promote satiety. It is indicated for general obesity, obesity associated with diabetes or hypertension, and hyperlipidemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Obenyl.